Vaxart
Why Robinhood?
You can watch Vaxart and buy or sell other stocks, ETFs, and their options commission-free!About VXRT
Vaxart, Inc. is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV).
VXRT Key Statistics
Stock Snapshot
With a market cap of 132.16M, Vaxart(VXRT) trades at $0.55. The stock has a price-to-earnings ratio of 3.66.
As of 2026-07-12, Vaxart(VXRT) stock has fluctuated between $0.52 and $0.59. The current price stands at $0.55, placing the stock +4.8% above today's low and -7.1% off the high.
The Vaxart(VXRT)'s current trading volume is 150.12K, compared to an average daily volume of 323.74K.
In the last year, Vaxart(VXRT) shares hit a 52-week high of $0.84 and a 52-week low of $0.31.
In the last year, Vaxart(VXRT) shares hit a 52-week high of $0.84 and a 52-week low of $0.31.
VXRT News
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
...
Vaxart (VXRT) announced topline data from the approximately 400-participant sentinel safety cohort of its Phase 2b clinical trial evaluating the company’s oral...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.